|
Apr 29
|
Stock Bulls Fuel Best Winning Run Since March 2022: Markets Wrap
|
|
Apr 29
|
Hims Stock Catapults After Inking Deal To Sell Novo Nordisk's Wegovy
|
|
Apr 29
|
Hims-Novo Nordisk partnership, SoFi earnings, Spotify guidance
|
|
Apr 29
|
Hims & Hers stock jumps on Novo Nordisk GLP-1 partnership
|
|
Apr 29
|
Hims & Hers with Novo Nordisk, Hilton, PayPal: Trending Tickers
|
|
Apr 29
|
Hims & Hers and Novo Nordisk Team Up to Expand Affordable Access to Care
|
|
Apr 25
|
Novo Nordisk wins case to kick knockoff Ozempic off the market, but it may not last
|
|
Apr 17
|
Eli Lilly stock soars on positive weight-loss pill results
|
|
Apr 16
|
April 2025's Top Growth Stocks With Strong Insider Confidence
|
|
Apr 14
|
Hims & Hers to Announce First Quarter 2025 Financial Results on May 5, 2025
|
|
Apr 4
|
Hims & Hers Health (NYSE:HIMS) Rises 5% Over Last Quarter Following Strong 2024 Earnings
|
|
Apr 3
|
Analysts Stay Cautious on HIMS Stock amid Core Business Uncertainty
|
|
Apr 2
|
Hims Claws Back After Its Lilly-Rivaling Obesity Plan Faces An Unexpected Hitch
|
|
Apr 2
|
Who Should Pay for Ozempic Is the Next Big Workplace Fight
|
|
Apr 1
|
Hims & Hers Expands Weight Loss Offering, Adds Lilly’s Zepbound to Platform
|
|
Apr 1
|
Hims & Hers adds Eli Lilly GLP-1 drugs, Johnson & Johnson setback
|
|
Apr 1
|
Hims Stock Jumps After Adding Eli Lilly's Obesity Drug To Its Platform
|
|
Apr 1
|
Hims & Hers Health, Inc.'s (NYSE:HIMS) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
|
|
Mar 13
|
They Wanted a Quick Fix for Hair Loss. Instead, These Young Men Got Sick.
|
|
Mar 13
|
Defiance Launches RKLX and HIMZ: 2X Leveraged ETFs for Rocket Lab and Hims & Hers
|